Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Lemborexant for the Treatment of Residual Insomnia in Adequately Treated Major Depressive Disorder: a Pilot Randomized Controlled Trial

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT06843187
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:49.523218+00:00
Published At
2025-02-24T00:00:00+00:00
Record Updated At
2025-02-24
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Major Depressive Disorder(MDD)", "Insomnia Comorbid to Psychiatric Disorder"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2025-02-24"
protocolSection.identificationModule.nctId
"NCT06843187"
protocolSection.identificationModule.officialTitle
"Lemborexant for the Treatment of Residual Insomnia in Adequately Treated Major Depressive Disorder: a Pilot Randomized Controlled Trial"
protocolSection.statusModule.overallStatus
"NOT_YET_RECRUITING"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Major Depressive Disorder(MDD) (protocolSection.conditionsModule.conditions)
  • Insomnia Comorbid to Psychiatric Disorder (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.